Treatment of Retinitis Pigmentosa with Intravitreal Injection of Etamsylate: Case Report
Journal of Clinical Medical Research · 10.05.2026 · 7 (2) · 1-3
DOI: 10.46889/jcmr.2026.7201 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Clinical Medical Research, online erschienen am 10.05.2026. Verfasst von Pedro Cuevas und 2 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Cystoid Macular Edema (CME) is a common complication of Retinitis Pigmentosa (RP) which increases with time and its treatment remains a challenge. Aberrant inflammation plays an essential role in RP. Here we report that local application of etamsylate, a powerful anti-inflammatory medicament, led to clinical improvement in a patient presenting this condition.
Zitieren
APA
Cuevas, P., Angulo, J., & Outeiriño, L. (2026). Treatment of Retinitis Pigmentosa with Intravitreal Injection of Etamsylate: Case Report. Journal of Clinical Medical Research, 7(2), 1-3. https://doi.org/10.46889/jcmr.2026.7201
Vancouver
Cuevas P, Angulo J, Outeiriño L. Treatment of Retinitis Pigmentosa with Intravitreal Injection of Etamsylate: Case Report. Journal of Clinical Medical Research. 2026;7(2):1-3. doi:10.46889/jcmr.2026.7201
BibTeX
@article{Cuevas2026,
author = {Cuevas, Pedro and Angulo, Javier and Outeiriño, Luis},
title = {Treatment of Retinitis Pigmentosa with Intravitreal Injection of Etamsylate: Case Report},
journal = {Journal of Clinical Medical Research},
year = {2026},
volume = {7},
number = {2},
pages = {1--3},
doi = {10.46889/jcmr.2026.7201}
}
EUVIMED